Loading portfolio…
Loading portfolio…
| # | Issuer | Value | Shares | % Portfolio |
|---|---|---|---|---|
| 1 | MAZE THERAPEUTICS INC | $123.0M | 4120053 | 18.16% |
| 2 | RAPPORT THERAPEUTICS INC | $116.7M | 3728738 | 17.23% |
| 3 | VIR BIOTECHNOLOGY INC | $115.7M | 12916663 | 17.09% |
| 4 | ERASCA INC | $114.7M | 7091557 | 16.95% |
| 5 | BEAM THERAPEUTICS INC | $108.2M | 4540132 | 15.98% |
| 6 | LYELL IMMUNOPHARMA INC | $65.1M | 3247162 | 9.62% |
| 7 | GENERATE BIOMEDICINES INC | $24.3M | 1944426 | 3.59% |
| 8 | 10X GENOMICS INC | $4.6M | 217834 | 0.68% |
| 9 | GOSSAMER BIO INC | $2.6M | 8055916 | 0.39% |
| 10 | Q32 BIO INC | $2.1M | 320482 | 0.30% |
Values in USD (reported in $thousands on 13F). Source: SEC EDGAR.